The analysis of SLC22A1 gene polymorphisms in 73 Tunisian patients with newly T2D showed that M420del and R61C, two established loss- of-function variants in SLC22A1, and G401S variant didn’t impair metformin efficacy. This evidence concerns the gene SLC22A1 and type 2 diabetes mellitus.